Office of Research Leadership & Staff

Dr. Mohler is also the executive vice president for Research, Innovation and Knowledge at Ohio State; chief scientific officer for the Ohio State Wexner Medical Center and Ohio State College of Medicine; and professor of Physiology & Cell Biology and Internal Medicine.

View my bio

Dana W. Glenn is the Senior Director overseeing the College of Medicine Grants Management Office (GMO). She provides leadership over the pre- and post-award operations in the GMO. This includes proposal submission, post-award financial reporting, other support reporting and assisting with award transfers for incoming faculty.

Dana.Glenn@osumc.edu

Dr. Golden-Kreutz is the senior director of the Center for Clinical Research Management within Ohio State College of Medicine and co-chair of the research leadership team for Healthy State Alliance at the Ohio State Wexner Medical Center.

Deanna.Golden-Kreutz@osumc.edu

Richard Gumina, MD, PhD, serves as the associate dean for Convergent Research, as well as associate professor of Internal Medicine, is a National Institutes of Health (NIH)-funded physician-scientist and an active interventional cardiologist. As the associate division director for Research, he works closely with the Center for Clinical Research Management and Clinical Trials and the Clinical Research Center to advance the translational and clinical research mission within cardiovascular medicine and the institution. Dr. Gumina currently leads the cardiovascular and STOP-COVID biorepositories, which incorporate a cross-disciplinary approach to advancing research across the medical center. As associate dean for Convergent Research, he builds strategies and infrastructure that expand translational research to support our health missions. He also oversees compliance related to human subjects research in the College of Medicine.

Paco Herson, PhD, is an experienced academic neuroscientist with a long-standing interest in translational research focused on therapies to reduce cell death and improve functional outcomes following cerebral ischemia, critical illness and injury. He serves as the associate dean for Research Innovation and oversees the Office of Research Innovation (ORI) to provide strategic vision and oversight related to technology, commercialization and external relationships. The ORI interacts with faculty, staff and learners to assist in education, intellectual property protection, early stage research and development, technology licensing, start-up formation and marketing. The ORI is a strong partner to all College of Medicine employees as they navigate the technology and commercialization process, amplifying the resources of the University and providing accountability and guidance.    

View my bio

Timothy Huerta, PhD, MS, serves as the associate dean for Research Information Technology, as well as a professor of Family and Community Medicine and Biomedical Informatics, the informatics lead for the Center for Clinical and Translation Science (CCTS), and is a senior member of the Center for the Advancement of Team Science, Analytics and Systems Thinking (CATALYST). As an NIH-, Agency for Healthcare Research and Quality (AHRQ)- and National Science Foundation (NSF)-funded scientist, he directs implementation science for the HEALing Communities Study, a $62M community-based opioid mortality reduction research study (one of the most significant grants at Ohio State), serves as the informatics lead for a study on traumatic brain injury documentation that involves hospitals from over 15 academic medical centers and leads a statewide project focused on reducing disparities in infant mortality in Ohio. In his role, Dr. Huerta supports strategy to align the growth of information technology for both the medical center and the college. He oversees and manages research technology for the college’s departments, institutes, and centers, increase faculty and staff engagement related to research informatics, build informatics platforms and data sources, and increase informatics-related innovation.

View my bio

Dana McTigue, PhD, professor of Neuroscience at the College of Medicine, serves as the associate dean for Foundational Research. She currently serves in a leadership role in the Belford Center for Spinal Cord Injury and as the vice chair for Diversity, Equity and Inclusion of her department. In her role, Dr. McTigue serves to support strategy to expand research in the basic sciences. She supports research proposal submission, research space governance and assignment, training grant data collection and oversight of vice chairs of Diversity, Equity and Inclusion in the basic science departments.

View my bio

Julie Johnson, PharmD, is director of the Clinical and Translational Science Institute (CTSI), serves as associate dean for Clinical and Translational Research in The Ohio State University College of Medicine and and is associate vice president of Research for The Ohio State University. She also holds the Dr. Samuel T. and Lois Felts Mercer Professorship of Medicine and Pharmacology. As director of the CCTS, Dr. Johnson will serve as the PI of a seven-year $37.9 million Clinical and Translation Science Award from the NIH.

View my bio

Kristy Townsend is currently the Faculty Lead for Research Operations and Compliance in the College of Medicine Office of Research. Townsend holds a PhD in Neuroscience and leads a research program focused on the Neurobiology of Energy Balance as faculty in the Department of Neurological Surgery. Townsend's research spans basic/foundational, translational and clinical studies, with a strong emphasis on innovation and commercialization/implementation of discoveries in healthcare and biomedical science. Townsend was previously Director of Women in Medicine and Science (WIMS) at Ohio State and previously founded the Women in STEMM (WiSTEMM) group at University of Maine, where she was faculty before being recruited to Ohio State in 2020. While leading WIMS, Townsend created the Research Accelerator Program to Translate, Innovate and Commercialize (RAPTIC), which is now being expanded across campus under her leadership and in partnership with ERIK's Health Science Innovation and the Clinical and Translational Science Institute (CTSI).